Halozyme Therapeutics logo
Halozyme Therapeutics HALO
$ 45.45 -0.69%

Quarterly report 2024-Q3
added 10-31-2024

report update icon

Halozyme Therapeutics Depreciation & Amortization 2011-2024 | HALO

Annual Depreciation & Amortization Halozyme Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
11.1 M 6.49 M 3 M 3.28 M 4.07 M 2.39 M 2.16 M 2.41 M 1.68 M 1.76 M 1.23 M 1.08 M 1.1 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
11.1 M 1.08 M 3.21 M

Quarterly Depreciation & Amortization Halozyme Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
2.6 M 2.6 M 2.44 M - 2.7 M 2.8 M 2.62 M - 2 M 1.1 M 778 K - 700 K 800 K 738 K - 800 K 800 K 857 K - 1 M 1 M 990 K - 600 K 600 K 566 K - 500 K 600 K 602 K - 700 K 600 K 489 K - 1.22 M 816 K 421 K - 1.3 M 840 K 397 K - 893 K 592 K 295 K - 796 K 510 K 238 K - 852 K 613 K 326 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
2.8 M 238 K 1.02 M